EUVIMEDEUVIMED entdecken
Open Access

Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023

Ellen W Stowe iD, Daniel K White iD, Michael A Boring, Kamil E Barbour, Tyler D Lites, Elizabeth A Fallon

Arthritis Care & Research · 2026-08 · 78 (8) · 967-973

DOI: 10.1002/acr.70018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, online erschienen am 29.12.2025. Verfasst von Ellen W Stowe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Arthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objectives of this study were (1) to estimate the 2023 prevalence of arthritis‐attributable activity limitations (AAAL) among US adults with arthritis overall and by selected sociodemographic and health characteristics and (2) to assess progress toward the Healthy People 2030 objective to reduce AAAL by describing the change in AAAL prevalence from 2019 to 2023.

Methods

Cross‐sectional data from the 2019 and 2023 National Health Interview Survey were used. Unadjusted and age‐standardized prevalences of AAAL in 2023 were estimated overall and by sociodemographic and health characteristics among US adults who reported having doctor‐diagnosed arthritis. Differences in the prevalence of AAAL by sociodemographic and health characteristics were assessed using t ‐tests. The overall unadjusted and age‐standardized prevalences of AAAL in 2019 were estimated and tested against 2023 estimates for differences by survey year (2019 and 2023).

Results

During 2023, an estimated 24.8 million adults with arthritis reported having an activity limitation (age‐adjusted prevalence, 47.8%; 95% confidence interval [CI], 45.0%–50.7%). There were significant differences in age‐adjusted AAAL prevalence by sociodemographic and health characteristics. Although there was a decline in the estimated age‐adjusted prevalence of AAAL from 2019 (49.2%; 95% CI, 46.7%–51.6%) to 2023, this change was not statistically significant.

Conclusion

About half of US adults with doctor‐diagnosed arthritis report activity limitations due to arthritis, and the Healthy People 2030 objective for an AAAL prevalence of 46.8% has not been met. Organizations, working individually or as partners, to implement arthritis‐appropriate evidence‐based interventions could contribute to achieving the Healthy People 2030 goal of reducing AAAL among US adults with arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArthritisHumansUnited StatesFemalePrevalenceCross-Sectional StudiesAdultMaleMiddle AgedAgedYoung AdultAdolescentHealth Surveys

Autor:innen und Institutionen

  • Centers for Disease Control and Prevention, Atlanta, Georgia.
  • University of Delaware, Newark.
  • Chenega Services & Federal Solutions, LLC.
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
  • Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee.

ORCID-Profile: Ellen W Stowe, Daniel K White

Förderung

  • Intramural CDC HHS

Zitieren

APA

Stowe, E. W., White, D. K., Boring, M. A., Barbour, K. E., Lites, T. D., & Fallon, E. A. (2026). Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023. Arthritis Care & Research, 78(8), 967-973. https://doi.org/10.1002/acr.70018

Vancouver

Stowe EW, White DK, Boring MA, Barbour KE, Lites TD, Fallon EA. Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023. Arthritis Care & Research. 2026;78(8):967-973. doi:10.1002/acr.70018

BibTeX
@article{Stowe2026,
  author = {Stowe, Ellen W and White, Daniel K and Boring, Michael A and Barbour, Kamil E and Lites, Tyler D and Fallon, Elizabeth A},
  title = {Prevalence of Arthritis‐Attributable Activity Limitations – United States, 2023},
  journal = {Arthritis Care & Research},
  year = {2026},
  volume = {78},
  number = {8},
  pages = {967--973},
  doi = {10.1002/acr.70018}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche